Loading…
HRS Aluglaze (BSE 544656)₹250.00−5.66%Industrial Products
In the Sep 2026 quarter (consolidated), HRS Aluglaze reported sales of ₹33.57 Cr, up 27.7% from Sep 2025, and net profit of ₹0.87 Cr, down 80.9% year on year. For the year to Mar 2026, sales were ₹67.41 Cr and net profit ₹10.23 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|
| Sales | 21.74 | 26.29 | 41.13 | 33.57 |
| Expenses | 17.97 | 17.88 | 31.69 | 29.86 |
| Operating Profit | 3.76 | 8.42 | 9.47 | 3.73 |
| OPM % | 17.4% | 32.1% | 23.0% | 11.1% |
| Other Income | 0.03 | 0.03 | 0.29 | 0.13 |
| Interest | 1.32 | 1.43 | 1.17 | 1.49 |
| Depreciation | 0.72 | 0.91 | 0.99 | 1.03 |
| Profit before tax | 1.76 | 6.11 | 7.62 | 1.33 |
| Tax % | 22.1% | 25.8% | 25.8% | 35.9% |
| Net Profit | 1.39 | 4.55 | 5.69 | 0.87 |
| EPS (Rs) | 1.00 | 3.26 | 2.96 | 0.64 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 42.04 | 67.41 |
| Expenses | 31.35 | 49.56 |
| Operating Profit | 10.68 | 17.91 |
| OPM % | 25.4% | 26.6% |
| Other Income | 0.03 | 0.30 |
| Interest | 2.50 | 2.61 |
| Depreciation | 1.36 | 1.89 |
| Profit before tax | 6.87 | 13.73 |
| Tax % | 25.2% | 25.8% |
| Exceptional items | 0.00 | 0.00 |
| Net Profit | 5.16 | 10.23 |
| EPS (Rs) | 3.69 | 5.31 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 6.67 | 19.31 |
| Reserves | 13.42 | 56.11 |
| Borrowings | 38.62 | 39.41 |
| Other Liabilities | 21.92 | 21.82 |
| Total Liabilities | 80.63 | 137 |
| Fixed Assets | 46.00 | 46.30 |
| CWIP | 0.36 | 15.60 |
| Investments | 0.00 | 7.51 |
| Other Assets | 34.27 | 67.24 |
| Inventories | 15.53 | 34.66 |
| Trade receivables | 13.23 | 17.77 |
| Cash & equivalents | 0.13 | 0.15 |
| Total Assets | 80.63 | 137 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | 3.94 | −11.06 |
| Cash from investing activity | −20.69 | −32.19 |
| Cash from financing activity | 16.79 | 43.19 |
| Net cash flow | 0.10 | 0.01 |
| Capex | 20.72 | 24.53 |
| Free cash flow | −16.71 | −35.05 |
| CFO / OP % | 41.0% | −48.1% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 114 | 96 |
| Inventory days | 294 | 398 |
| Days payable | 223 | 153 |
| Cash conversion cycle | 184 | 339 |
| Working capital days | −26 | 117 |
| ROCE % | — | 18.8% |
For the Sep 2026 quarter, HRS Aluglaze reported sales of ₹33.57 Cr, up 27.7% year on year and net profit of ₹0.87 Cr, down 80.9% year on year. The operating margin was 11.1%.
HRS Aluglaze's sales for the year to Mar 2026 were ₹67.41 Cr.
Net profit for the year to Mar 2026 was ₹10.23 Cr. Earnings per share over the same trailing period were ₹5.31.
HRS Aluglaze reported borrowings of ₹39.41 Cr at Mar 2026, against cash and equivalents of ₹0.15 Cr.
Cash from operations was −₹11.06 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹35.05 Cr.